systematic_review
2003
High Quality
Kava extract for treating anxiety disorders: a Cochrane systematic review
Pittler MH, Ernst E
Published in Cochrane Database of Systematic Reviews
Methodology
Cochrane review of randomised placebo-controlled trials of kava extract for anxiety including social anxiety symptoms.
Key Findings
Kava extract significantly reduced Hamilton Anxiety scores compared with placebo, with a small but significant pooled effect and rare hepatotoxicity concerns.
Conclusions
Kava reduces anxiety symptoms but carries liver-safety caveats.
Limitations
Short trials; hepatotoxicity reports led to withdrawals.
Outcomes Measured
Social Anxiety Reduction
Primary
Kava extract significantly reduced Hamilton Anxiety scores compared with placebo
Related Health Concerns
Study Details
Year:2003
Sample Size:645
Duration:4 weeks
Quality Score:8/10
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.